Forest Labs, Lupin ink marketing agreement for AeroChamber Plus

MUMBAI, India United States-based generic drug manufacturer Forest Laboratories and India-based Lupin have signed a marketing agreement for Forest’s AeroChamber Plus.

AeroChamber Plus is a holding chamber device used to improve delivery of asthma and chronic obstructive pulmonary disease medications, according to Thomson Financial.

New York-based Forest is known for products such as Lexapro (escitalopram oxalate), a drug for treating depressive disorder and anxiety disorder, and the blood-pressure drug Bystolic (nebivolol).